The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
A Link between Serotonin-Related Gene Polymorphisms, Amygdala Activity, and Placebo-Induced Relief from Social Anxiety
Open accessAbstract
Placebo may yield beneficial effects that are indistinguishable from those of active medication, but the factors underlying proneness to respond to placebo are widely unknown. Here, we used functional neuroimaging to examine neural correlates of anxiety reduction resulting from sustained placebo treatment under randomized double-blind conditions, in patients with social anxiety disorder. Brain activity was assessed during a stressful public speaking task by means of positron emission tomography before and after an 8 week treatment period. Patients were genotyped with respect to the serotonin transporter-linked polymorphic region (5-HTTLPR) and the G-703T polymorphism in the tryptophan hydroxylase-2 (TPH2) gene promoter. Results showed that placebo response was accompanied by reduced stress-related activity in the amygdala, a brain region crucial for emotional processing. However, attenuated amygdala activity was demonstrable only in subjects who were homozygous for the long allele of the 5-HTTLPR or the G variant of the TPH2 G-703T polymorphism, and not in carriers of short or T alleles. Moreover, the TPH2 polymorphism was a significant predictor of clinical placebo response, homozygosity for the G allele being associated with greater improvement in anxiety symptoms. Path analysis supported that the genetic effect on symptomatic improvement with placebo is mediated by its effect on amygdala activity. Hence, our study shows, for the first time, evidence of a link between genetically controlled serotonergic modulation of amygdala activity and placebo-induced anxiety relief.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Elevated SLC6A4 methylation is also associated with generalized anxiety disorder (GAD) and panic disorder, correlates with increased anxiety traits, social anxiety, and amygdala hyperreactivity”
From The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry (2025) · cites this paper as [107]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
(1998) · PubMed · Cited by 10,216
Statistical parametric maps in functional imaging: A general linear approach
Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D. V., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,899
Maldjian, J. A., Laurienti, P. J., Kraft, R., & Burdette, J. H. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00169-1 · Cited by 5,066
Mattick, R. P., & Clarke, J. C. (1998) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(97)10031-6 · Cited by 3,367
Serotonin transporter genetic variation and the response of the human amygdala.
Hariri, A. R., Mattay, V. S., Tessitore, A., Kolachana, B., Fera, F., Goldman, D., Egan, M. F., & Weinberger, D. R. (2002) · Science · doi:10.1126/science.1071829 · Cited by 2,340
Liebowitz, M. R. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000414022 · Cited by 2,266
Research works printed but not linked: 1
- Raftery AE (1993) in Testing structural equation models, Bayesian model selection in structural equation models, eds Bollen KA Long JS (Sage Publications, Newbury Park, CA), pp 163–180.
Cited by
Sorted by citations
Items 101–200 of 209
Frick, A., Åhs, F., Appel, L., Jonasson, M., Wahlstedt, K., Bani, M., Merlo Pich, E., Bettica, P., Långström, B., Lubberink, M., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.09.004 · Cited by 22
Self-citationTamura, Y., Takata, K., Matsubara, K., & Kataoka, Y. (2021) · Nutrients · doi:10.3390/nu13062091 · Cited by 20
Does the model of additive effect in placebo research still hold true? A narrative review
Boehm, K., Berger, B., Weger, U., & Heusser, P. (2017) · JRSM Open · doi:10.1177/2054270416681434 · Cited by 20
Kraus, J., Frick, A., Fischer, H., Howner, K., Fredrikson, M., & Furmark, T. (2018) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2018.08.012 · Cited by 22
Self-citationPlacebo-mediated, Naloxone-sensitive suggestibility of short-term memory performance
Stern, J., Candia, V., Porchet, R. I., Krummenacher, P., Folkers, G., Schedlowski, M., Ettlin, D. A., & Schönbächler, G. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.01.005 · Cited by 20
Chronic intranasal oxytocin reverses stress-induced social avoidance in female prairie voles
Hale, L. H., Tickerhoof, M. C., & Smith, A. S. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108770 · Cited by 19
Knowledge Gaps in Placebo Research: With Special Reference to Neurobiology
Enck, P., Horing, B., Broelz, E. K., & Weimer, K. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.018 · Cited by 19
The placebo phenomenon and the underlying mechanisms
Theodosis‐Nobelos, P., Filotheidou, A., & Triantis, C. (2020) · HORMONES · doi:10.1007/s42000-020-00243-5 · Cited by 22
Issues and controversies surrounding the diagnosis and treatment of social anxiety disorder
Dalrymple, K. L. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.81 · Cited by 21
Clinical improvement of vasovagal syncope in the absence of specific therapies: The Seinfeld effect
Sahota, I. S., Sheldon, R. S., & Pournazari, P. (2014) · Cardiology Journal · doi:10.5603/cj.2014.0096 · Cited by 18
Breidert, M., & Hofbauer, K. G. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0751 · Cited by 20
Heritability of social anxiety disorder: a systematic review of methodological designs
Moreno, A. L., Osório, F. D. L., Martín‐Santos, R., & Crippa, J. A. S. (2016) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/0101-60830000000090 · Cited by 17
Placebo forte: Ways to maximize unspecific treatment effects
Schneider, R., & Kühl, J. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.02.022 · Cited by 18
Does Case Formulation Make a Difference to Treatment Outcome?
Ghaderi, A. (2011) · doi:10.1002/9781119977018.ch3 · Cited by 17
A brain network response to sham surgery.
Cherkasova, M., & Stoessl, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci77193 · Cited by 2
Effects of Open-Label Placebos on State Anxiety and Glucocorticoid Stress Responses
Schaefer, M., Hellmann‐Regen, J., & Enge, S. (2021) · Brain Sciences · doi:10.3390/brainsci11040508 · Cited by 16
Carballo, J. J., Currier, D., Figueroa, A. E., Giner, L., Kelly, S. A., Sublette, M. E., & Oquendo, M. A. (2009) · The European Journal of Psychiatry · doi:10.4321/s0213-61632009000400005 · Cited by 15
Creating Placebo Responders and Nonresponders in the Laboratory: Boons and Banes
Benedetti, F., & Frisaldi, E. (2014) · Pain Management · doi:10.2217/pmt.14.11 · Cited by 15
Colloca, L. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.04.001 · Cited by 15
Genetics of social anxiety disorder: a systematic review
Baba, A., Kloiber, S. M., & Zai, G. C. (2021) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000310 · Cited by 13
Su, Y., Li, J., Dai, W., Liao, X.-M., Dong, L., Lu, T., Bousman, C., & Si, T. (2016) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000115 · Cited by 14
Hu, L.-X., Wang, D., Liu, H., Zhang, Q., Sun, D., Zhang, L., Chen, X., Chang, G., & Wang, J. (2021) · Journal of Clinical Hypertension · doi:10.1111/jch.14207 · Cited by 12
Laeger, I., Dobel, C., Radenz, B., Kugel, H., Roesmann, K., Eden, A. S., Arolt, V., Zwitserlood, P., Dannlowski, U., & Zwanzger, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109949 · Cited by 12
Johnson, S. B., & Anderson, P. L. (2016) · Anxiety Stress & Coping · doi:10.1080/10615806.2016.1138289 · Cited by 14
Thoeringer, C. K., Pfeiffer, U. J., Rammes, G., Pamplona, F. A., Moosmang, S., & Wotjak, C. T. (2010) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2010.00634.x · Cited by 12
Weber, S., Álvarez, L. T. R., Ansede‐Bermejo, J. J., Cruz, R., del Real, Á., Bühler, J., Carracedo, Á., & Aybek, S. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111909 · Cited by 11
Åhs, F., Gingnell, M., Furmark, T., & Fredrikson, M. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.01.009 · Cited by 12
Self-citationValenzuela, M., David Bartrés-faz, A., Beg, M. F., Fornito, A., Merlo‐Pich, E., Müller, U., Öngür, D., Toga, A. W., & Yücel, M. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.62 · Cited by 11
Burke, M. J., Sandra, D. A., Peciña, M., Olson, J. A., Mollica, A., Butler, M., Moss, J. H., Nicholson, T. R., Wager, T. D., & Kaptchuk, T. J. (2026) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00340-2 · Cited by 12
Genetic Susceptibility of Impulse Control and Related Behavior in Parkinson's Disease
Kim, Y. E., & Jeon, B. S. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-130292 · Cited by 9
Placebo Effects in Therapeutic Outcomes
Horin, A. P., Lee, K., & Colloca, L. (2014) · Current Clinical Pharmacology · doi:10.2174/1574884708999140101145528 · Cited by 9
Can we harness the placebo effect to improve care in lower urinary tract dysfunction? ICI‐RS 2019
Khullar, V., Rahnama’i, M. S., Veit‐Rubin, N., Cardozo, L., & Wein, A. J. (2020) · Neurourology and Urodynamics · doi:10.1002/nau.24351 · Cited by 8
Neuroendocrinology and Neuroimaging Studies of Social Anxiety Disorder
Phan, K. L., & Klumpp, H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375096-9.00010-9 · Cited by 9
Words and Drugs: Same Mechanisms of Action?
Piedimonte, A., & Benedetti, F. (2015) · Journal of Contemporary Psychotherapy · doi:10.1007/s10879-015-9321-4 · Cited by 7
Perspectives on Placebo: The Psychology of Neurofeedback
Thornton, K. (2018) · NeuroRegulation · doi:10.15540/nr.5.4.137 · Cited by 5
Placebo, Nocebo, and Patient-Reported Outcome Measures in Drug Allergy
Bavbek, S., Özyiğit, L. P., Baiardini, I., Braido, F., Gigia Roizen, G., & Jerschow, E. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.11.033 · Cited by 7
‘Oxytocin’ for the outwardly oriented: Evidence for interactive effects in placebo responding
Darragh, M., Booth, R. J., & Consedine, N. S. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.02.001 · Cited by 7
Relationships of Genes and Early‐Life Experience to the Neurobiology of Suicidal Behaviour
Mann, J. J., & Currier, D. (2011) · Wiley eBooks · doi:10.1002/9781119998556.ch8 · Cited by 6
Influences of hypnotic suggestibility, contextual factors, and EEG alpha on placebo analgesia
Pascalis, V. D., Scacchia, P., & Vecchio, A. (2021) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.2020.1863182 · Cited by 8
Emotion appraisal and the tryptophan hydroxylase 2 (TPH2) gene
Szily, E., & Kéri, S. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0769-z · Cited by 6
Neurotransmission: A Review of PET and SPECT Studies in Anxiety Disorders
Fredrikson, M., Faria, V., & Furmark, T. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_13 · Cited by 6
Self-citationSwallow, E., Fang, A., Signorovitch, J., Plumb, J., & Borghs, S. (2017) · CNS Drugs · doi:10.1007/s40263-017-0462-8 · Cited by 6
Placebo: Missverständnisse und Vorurteile
Breidert, M., & Hofbauer, K. G. (2010) · Osteopathische Medizin · doi:10.1016/j.ostmed.2010.03.001 · Cited by 6
Placebo Response and Placebo Effect
Benedetti, F., & Shaibani, A. I. (2025) · Neurologic Clinics · doi:10.1016/j.ncl.2025.08.001 · Cited by 5
Kumar, P., Harmer, C. J., & Dourish, C. T. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386945-6.00012-3 · Cited by 6
Haug-Baltzell, A., Bhangale, T., Chang, D., Dressen, A., Yaspan, B., Ortmann, W., Brauer, M., Hunkapiller, J., Reeder, J., Mukhyala, K., et al. (2018) · Genes and Immunity · doi:10.1038/s41435-018-0018-z · Cited by 3
Викторовна, М. П., Shnayder, N. A., Дмитренко, Д. В., Сергеевна, Ш. О., Незнанов, Н. Г., & Nasyrova, R. F. (2022) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-022-01260-0 · Cited by 5
Montel Hayes, R., Mason, C. E., & Miller, J. J. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1671122 · Cited by 5
Compreendendo o Efeito Placebo / Understanding the Placebo Effect
Dias, E. V., & Sartori, C. R. (1970) · REVISTA CIÊNCIAS EM SAÚDE · doi:10.21876/rcsfmit.v5i4.399 · Cited by 3
Approach and avoidance personality traits in acute pain and placebo analgesia
Vecchio, A., & Pascalis, V. D. (2020) · Personality and Individual Differences · doi:10.1016/j.paid.2020.109830 · Cited by 5
Neurogenetics Approaches to Mapping Pathways in Developmental Psychopathology
Hyde, L. W., Swartz, J. R., Waller, R. E., & Hariri, A. R. (2016) · Wiley eBooks · doi:10.1002/9781119125556.devpsy212 · Cited by 4
Kang, H., Miksche, M. S., & Ellingsen, D. (2022) · doi:10.31234/osf.io/tc9e8 · Cited by 4
Brown, C. A., Watson, A., Morton, D. L., Power, A., El‐Deredy, W., & Jones, A. K. P. (2011) · Future Neurology · doi:10.2217/fnl.11.21 · Cited by 3
What is the role of placebo in neurotherapeutics?
Frisaldi, E., Shaibani, A. I., Trucco, M., Milano, E., & Benedetti, F. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2012156 · Cited by 3
Less Pain, More Gain: Should Placebo Be a Clinical Therapeutic?
Uchendu, S., & Wang, A. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41168 · Cited by 3
Yeh, P., Lin, C., Sun, C., & Tung, S.-Y. (2025) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-025-01560-9 · Cited by 4
Influence of a Suggestive Placebo Intervention on Psychobiological Responses to Social Stress
Zimmermann‐Viehoff, F., Steckhan, N., Meißner, K., Deter, H., & Kirschbaum, C. (2015) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587215588642 · Cited by 2
Anxiety disorders: genetic mechanisms
Domschke, K. (2013) · e-Neuroforum · doi:10.1007/s13295-013-0044-2 · Cited by 4
Are all placebo respondents non-smokers?
Enck, P., Weimer, K., & Klosterhalfen, S. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.06.012 · Cited by 2
Placebo response and improving outcomes with active medication
Greener, M. (2009) · Nurse Prescribing · doi:10.12968/npre.2009.7.5.42358 · Cited by 2
Leigh, H. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5671-2_11 · Cited by 2
Placeboeffekte und ihre Implikationen in der Medizin
Bingel, U. (2014) · Uro-News · doi:10.1007/s00092-014-0033-y · Cited by 2
Placebo Effects and Functional Neurological Disorder: Helpful or Harmful?
Burke, M. J., & Lidstone, S. C. (2022) · Current clinical neurology · doi:10.1007/978-3-030-86495-8_27 · Cited by 2
The Social Neuroscience of Social Anxiety Disorder
Syal, S., & Stein, D. J. (2014) · Wiley eBooks · doi:10.1002/9781118653920.ch4 · Cited by 2
Furmark, T., Wahlstedt, K., & Faria, V. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1531725 · Cited by 1
Self-citationBenedetti, F., & Shaibani, A. I. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-29884-4.00009-1 · Cited by 1
Placebo effects in mental disorders
Wilhelm, M., Rief, W., & Salzmann, S. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-29884-4.00016-9 · Cited by 1
Placeboeffekte und ihre Implikationen in der Medizin
Bingel, U. (2014) · HNO Nachrichten · doi:10.1007/s00060-014-0281-1 · Cited by 1
Placebo: een ingewikkeld fenomeen
Olivier, J., & Olivier, B. (2016) · Neuropraxis · doi:10.1007/s12474-016-0130-7 · Cited by 1
How Placebo Responses are Formed: From Bench to Bedside
Colloca, L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397928-5.00014-3 · Cited by 2
A modern view of placebo and placebo-related effects
Benedetti, F. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780198843177.003.0008 · Cited by 1
de Bruijn, C. M. A., Hovy, S. W., Tromp, E., Benninga, M. A., Hall, K. T., & Vlieger, A. M. (2023) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003895 · Cited by 1
Vigencia del efecto placebo: su biología desde la genética a la conducta
Diana Aceituno, V., & Santander, J. (2017) · Revista médica de Chile · doi:10.4067/s0034-98872017000600775 · Cited by 1
Mental and behavioural disorders
Benedetti, F. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780198843177.003.0012 · Cited by 1
Placebo- and nocebo-induced pain modulation: from bedside to bench and back to bedside
Colloca, L. (2014) · Douleur et Analgésie · doi:10.1007/s11724-014-0401-4 · Cited by 1
Frisaldi, E., Barbiani, D., & Benedetti, F. (2017) · Oxford University Press eBooks · doi:10.1093/obo/9780199828340-0196 · Cited by 1
Relationships of Genes and Early‐Life Experience to the Neurobiology of Suicidal Behavior
Mann, J. J., & Currier, D. (2016) · Wiley eBooks · doi:10.1002/9781118903223.ch9 · Cited by 1
Colloca, L., Horin, A. P., & Finniss, D. G. (2016) · Wiley eBooks · doi:10.1002/9781118455968.ch9 · Cited by 1
The Influence of Dopamine on the Magnitude and Duration of the Placebo Effect
Brewer, S. T. (2014) · ScholarWorks @ The University of New Orleans (The University of New Orleans)
Placeboeffekte und ihre Implikationen in der Neurologie
Bingel, U. (2014) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-013-0310-4
Neurobiologie der Plazebowirkung
Müller, M. J. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_52
On the influence of dopamine-related genetic variation on dopamine-related disorders
Bergman, O. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Praktische Bedeutung der Genetik bei Angststörungen
Domschke, K. (2012) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Brewer, S. T. (2011) · ScholarWorks @ The University of New Orleans (The University of New Orleans)
Depression and Cancer: A Role for 5-HTTLPR and SSRI Antidepressant Drugs?
Giraldi, T., & Schillani, G. (2013) · Neuropathological diseases · doi:10.1615/neuropatholdiseases.v2.i1.40
Psychische Faktoren gastrointestinaler Erkrankungen
Hefner, J., Klosterhalfen, S., Martens, U., & Enck, P. (2010) · Psychotherapeut · doi:10.1007/s00278-010-0744-9
Bresjanac, M. (2015) · Repository of the University of Ljubljana (University of Ljubljana)
The genetic influence on the placebo effect specific to exercise performance
Wu, J. J. (2011) · JMU Scholoraly Commons (James Madison University)
Placeboeekte und ihre Implikationen in der Medizin
Bingel, U. (2014)
Judah, M. R. (2016) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University)
Giraldi, T. (2017) · Springer eBooks · doi:10.1007/978-3-319-57657-2_10
Valencia, H. O. (2016) · UPCommons institutional repository (Universitat Politècnica de Catalunya) · doi:10.5821/dissertation-2117-109351
Implications of placebos and nocebos in clinical research
Colloca, L., & Haycock, N. R. (2018) · PNEI REVIEW · doi:10.3280/pnei2018-001009
Social anxiety disorder : Functional neuroimaging and social cognitive features
Doruyter, A. (2018) · SUNScholar (Stellenbosch University)
Respuesta placebo en la enfermedad de Parkinson: una revisión teórica
Pérez‐Muñoz, C., Cavas, M., & Navarro, J. F. (2018) · Psiquiatría Biológica · doi:10.1016/j.psiq.2018.09.001
Genetic Neuroimaging of Social Perception
Faig, K. E., Nikolova, Y. S., & Hariri, A. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00161-5
Placeboeffekte und ihre Implikationen in der Medizin
Bingel, U. (2020) · Schmerzmedizin · doi:10.1007/s00940-020-0593-8
Neuroendocrinology and Neuroimaging Studies of Social Anxiety Disorder
Phan, K. L., & Klumpp, H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-394427-6.00012-1
Der Mensch – ein unterentwickelter Computer?
Gründer, G. (2020) · Springer eBooks · doi:10.1007/978-3-662-61713-7_4
PET and SPECT Studies in Anxiety Disorders
Faria, V., Fredrikson, M., & Furmark, T. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_10 · Cited by 1
Self-citation
Metadata
- Authors
- Furmark, T., Appel, L., Henningsson, S., Åhs, F., Faria, V., Linnman, C., Pissiota, A., Frans, Ö., Bani, M., Bettica, P., Pich, E. M., Jacobsson, E., Wahlstedt, K., Oreland, L., Långström, B., Eriksson, E., & Fredrikson, M.
- Affiliations
- Uppsala University (SE)
- University of Gothenburg (SE)
- GlaxoSmithKline (Italy) (IT)
- Corresponding author
- Furmark, Tomas
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-12-03
- Volume
- 28
- Issue
- 49
- Pages
- 13066-13074
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6671592
- OpenAlex
- W2161011520
- Cited by
- 210
- References
- 60
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 1 · 2023: 3 · 2022: 10 · 2021: 8 · 2020: 14 · 2019: 5 · 2018: 11 · 2017: 13 · 2016: 17 · 2015: 14 · 2014: 25 · 2013: 15 · 2012: 18
- FWCI
- 7.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- GlaxoSmithKline
- Vetenskapsrådet
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- placebo response, social anxiety disorder, serotonin, 5-HTTLPR, tryptophan hydroxylase 2, amygdala activity, genetic polymorphism, public speaking stress, serotonergic modulation
- MeSH terms
- Adult, Amygdala, Anxiety Disorders, DNA Mutational Analysis, Double-Blind Method, Female, Gene Frequency, Genetic Testing, Genotype, Humans, Male, Middle Aged, Neuropsychological Tests, Polymorphism, Genetic, Serotonin, Stress, Psychological, Tryptophan Hydroxylase, Placebo Effect, Genetic Predisposition to Disease, Positron-Emission Tomography, Serotonin Plasma Membrane Transport Proteins, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review